Foster Victor Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.9M | Buy |
819,225
+33,570
| +4% | +$878K | 1.04% | 27 |
|
|
2026
Q1 | $21.3M | Buy |
785,655
+89,704
| +13% | +$2.39M | 1.22% | 21 |
|
|
2025
Q4 | $17.9M | Sell |
695,951
-9,307
| -1% | -$235K | 1.04% | 34 |
|
|
2025
Q3 | $19.3M | Buy |
705,258
+60,667
| +9% | +$1.5M | 1.2% | 24 |
|
|
2025
Q2 | $16.5M | Buy |
644,591
+46,116
| +8% | +$1.08M | 1.12% | 32 |
|
|
2025
Q1 | $13.1M | Buy |
598,475
+34,440
| +6% | +$901K | 1.05% | 36 |
|
|
2024
Q4 | $14.8M | Buy |
564,035
+112,616
| +25% | +$3.05M | 1.14% | 28 |
|
|
2024
Q3 | $13.6M | Buy |
451,419
+18,162
| +4% | +$530K | 1.09% | 31 |
|
|
2024
Q2 | $12.8M | Buy |
433,257
+21,315
| +5% | +$587K | 1.07% | 37 |
|
|
2024
Q1 | $10.9M | Buy |
411,942
+45,987
| +13% | +$1.28M | 0.99% | 48 |
|
|
2023
Q4 | $10.8M | Buy |
365,955
+70,523
| +24% | +$2.13M | 1.11% | 42 |
|
|
2023
Q3 | $9.79M | Buy |
295,432
+112,675
| +62% | +$3.98M | 1.14% | 40 |
|
|
2023
Q2 | $6.66M | Buy |
182,757
+26,495
| +17% | +$1.03M | 0.74% | 54 |
|
|
2023
Q1 | $6.39M | Buy |
156,262
+22,398
| +17% | +$967K | 0.77% | 52 |
|
|
2022
Q4 | $6.82M | Buy |
133,864
+9,535
| +8% | +$457K | 0.87% | 51 |
|
|
2022
Q3 | $5.36M | Buy |
124,329
+11,165
| +10% | +$543K | 0.78% | 56 |
|
|
2022
Q2 | $5.97M | Buy |
113,164
+8,239
| +8% | +$420K | 0.89% | 53 |
|
|
2022
Q1 | $5.55M | Buy |
104,925
+13,174
| +14% | +$684K | 0.76% | 54 |
|
|
2021
Q4 | $5.2M | Sell |
91,751
-3,950
| -4% | -$196K | 0.71% | 56 |
|
|
2021
Q3 | $4.12M | Sell |
95,701
-3,313
| -3% | -$147K | 0.66% | 53 |
|
|
2021
Q2 | $3.88M | Buy |
99,014
+9,426
| +11% | +$367K | 0.65% | 53 |
|
|
2021
Q1 | $3.33M | Buy |
89,588
+16,831
| +23% | +$598K | 0.62% | 48 |
|
|
2020
Q4 | $2.68M | Buy |
72,757
+2,354
| +3% | +$86.3K | 0.61% | 45 |
|
|
2020
Q3 | $2.45M | Buy |
70,403
+4,667
| +7% | +$164K | 0.66% | 45 |
|
|
2020
Q2 | $2.04M | Buy |
65,736
+4,728
| +8% | +$161K | 0.68% | 42 |
|
|
2020
Q1 | $2.06M | Buy |
61,008
+9,055
| +17% | +$309K | 0.9% | 43 |
|
|
2019
Q4 | $1.93M | Buy |
51,953
+11,143
| +27% | +$397K | 0.83% | 42 |
|
|
2019
Q3 | $1.39M | Buy |
40,810
+20,686
| +103% | +$752K | 0.77% | 38 |
|
|
2019
Q2 | $827K | Sell |
20,124
-1,965
| -9% | -$78K | 0.61% | 37 |
|
|
2019
Q1 | $890K | Buy |
22,089
+1,070
| +5% | +$42.9K | 0.69% | 24 |
|
|
2018
Q4 | $870K | Buy |
+21,019
| New | +$873K | 0.82% | 14 |
|
Other funds holding PFE
Foster Victor Wealth Advisors's PFE Position: Q2 2026 in Review
Foster Victor Wealth Advisors increased its Pfizer (PFE) stake by 4.3% in Q2 2026, buying an estimated $878K and bringing the position to 819,225 shares worth $19.9M. The position accounts for 1.04% of the portfolio, ranked #27.
Foster Victor Wealth Advisors first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $21.3M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Foster Victor Wealth Advisors held 819,225 shares of Pfizer worth $19.9M as of Q2 2026.
- Foster Victor Wealth Advisors bought 33,570 Pfizer shares in Q2 2026, an estimated $878K.
- Pfizer made up 1.04% of Foster Victor Wealth Advisors's portfolio in Q2 2026, its #27 holding.
- Foster Victor Wealth Advisors first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Foster Victor Wealth Advisors's Pfizer position peaked at $21.3M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Foster Victor Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.